This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
One thing is for sure—regardless of how the field evolves around regulation requirements, Altasciences has the experience and range of capabilities to take on your gene therapy drug development programs. Final Thoughts It goes without saying (but I’ll say it anyway): Cell and gene therapy is a field in rapid evolution.
Our data demonstrate that the CoREST complex is a critical mediator of the distinct melanoma phenotypes, working through the regulation of both the phenotype-defining genes MITF and AXL as well as the master regulators of epithelial-to-mesenchymal transitions (EMT) and phenotype switching in melanoma and other cancers, SNAIL/SLUG/ZEB1/ZEB2.
Progress in molecularbiology and translational science. Α-synuclein in the pathophysiology of alzheimer’s disease – molecular neurodegeneration. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in alzheimer’s disease – acta neuropathologica.
Longwood has a robust research department with 7 post doctorates conducting research in molecularbiology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Link to her profile: [link]. About Longwood University.
During my doctoral training, I split my work between wet lab research and programming, two streams that differed radically in terms of productivity. Ultimately, no matter the model organism or where it comes from, molecularbiology will probably never approach the speed of computer programming. The resulting strain of V.
Regulators traditionally want to see a single, stable, well-characterized drug before giving the green light for it to be tested in a clinical trial, not dozens of different viruses; let alone ones that are best found in unappealing places like sewage , hospital waste, or bird poop.
in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” These protein:RNA duos seem to regulate gene expression in a way that we don’t really understand.
in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” These protein:RNA duos seem to regulate gene expression in a way that we don’t really understand.
Other surgical domains, such as various thoracic procedures, have been modernized by the addition of robots, which similarly aid doctors in precision and delicacy. In ideal circumstances, our circadian rhythms work well and regulate our hormonal cycles and mood. How, exactly, might one turn the ship around and reinvigorate science?
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content